{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T09:53:04Z","timestamp":1774691584431,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Biochem Biotechnol"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s12010-026-05584-2","type":"journal-article","created":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T09:35:14Z","timestamp":1768901714000},"page":"2513-2525","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effects of\u2002(5R)-5-Hydroxytriptolide Against\u2002Rheumatoid\u2002Arthritis: Intervention on the Transformation of Bone Marrow Cells Induced Osteoclasts Bone Erosion and Angiogenesis"],"prefix":"10.1007","volume":"198","author":[{"given":"Ya","family":"Yan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Nie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanling","family":"Lian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,20]]},"reference":[{"key":"5584_CR1","doi-asserted-by":"crossref","unstructured":"Wang, L., Hong, X., & Du, H. (2023). Association between serum chemokine ligand 20 levels and disease activity and Th1\/Th2\/Th17-related cytokine levels in rheumatoid arthritis. Journal of Interferon & Cytokine Research, 43, 512\u2013517.","DOI":"10.1089\/jir.2023.0057"},{"key":"5584_CR2","doi-asserted-by":"publisher","first-page":"115456","DOI":"10.1016\/j.ejmech.2023.115456","volume":"257","author":"Q Chen","year":"2023","unstructured":"Chen, Q., Chen, Z., Li, F., Zha, H., He, W., Jiang, F., Wei, J., Xu, J., Li, R., Cai, L., & Liu, X. (2023). Discovery of highly potent and selective VEGFR2 kinase inhibitors for the treatment of rheumatoid arthritis. European Journal of Medicinal Chemistry, 257, 115456.","journal-title":"European Journal of Medicinal Chemistry"},{"key":"5584_CR3","doi-asserted-by":"publisher","first-page":"953","DOI":"10.26719\/2010.16.9.953","volume":"16","author":"SM Attar","year":"2010","unstructured":"Attar, S. M., & Al-Ghamdi, A. (2010). Radiological changes in rheumatoid arthritis patients at a teaching hospital in Saudi Arabia. Eastern Mediterranean Health Journal, 16, 953\u2013957.","journal-title":"Eastern Mediterranean Health Journal"},{"key":"5584_CR4","first-page":"e5695","volume":"11","author":"MG Attalla","year":"2019","unstructured":"Attalla, M. G., Singh, S. B., Khalid, R., Umair, M., & Epenge, E. (2019). Relationship between ulcerative colitis and rheumatoid arthritis: A review. Cureus, 11, e5695.","journal-title":"Cureus"},{"key":"5584_CR5","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1134\/S1607672923700308","volume":"511","author":"VN Amirdzhanova","year":"2023","unstructured":"Amirdzhanova, V. N., Karateev, A. E., Pogozheva, E. Y., Filatova, E. S., Samigullina, R. R., Mazurov, V. I., Anoshenkova, O. N., Lapkina, N. A., Baranov, A. A., Grineva, T. Y., Lila, A. M., & Nasonov, E. L. (2023). Are the goals of therapy achievable in patients with rheumatoid arthritis receiving Upadacitinib in real clinical practice? Doklady Biochemistry and Biophysics, 511, 180\u2013186.","journal-title":"Doklady Biochemistry and Biophysics"},{"key":"5584_CR6","doi-asserted-by":"publisher","first-page":"1150661","DOI":"10.3389\/fimmu.2023.1150661","volume":"14","author":"Z Long","year":"2023","unstructured":"Long, Z., Zeng, L., He, Q., Yang, K., Xiang, W., Ren, X., Deng, Y., & Chen, H. (2023). Research progress on the clinical application and mechanism of Iguratimod in the treatment of autoimmune diseases and rheumatic diseases. Frontiers in Immunology, 14, 1150661.","journal-title":"Frontiers in Immunology"},{"key":"5584_CR7","doi-asserted-by":"publisher","first-page":"107472","DOI":"10.1016\/j.intimp.2021.107472","volume":"94","author":"J Fu","year":"2021","unstructured":"Fu, J., Zang, Y., Zhou, Y., Chen, C., Shao, S., Shi, G., Wu, L., Zhu, G., Sun, T., Zhang, D., & Zhang, T. (2021). Exploring a novel triptolide derivative possess anti-colitis effect via regulating T cell differentiation. International Immunopharmacology, 94, 107472.","journal-title":"International Immunopharmacology"},{"key":"5584_CR8","doi-asserted-by":"publisher","first-page":"114470","DOI":"10.1016\/j.biopha.2023.114470","volume":"161","author":"S Jiang","year":"2023","unstructured":"Jiang, S., Wan, F., Lian, H., Lu, Z., Li, X., Cao, D., Jiang, Y., & Li, J. (2023). Friend or foe? The dual role of triptolide in the liver, kidney, and heart. Biomedicine & Pharmacotherapy, 161, 114470.","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"5584_CR9","doi-asserted-by":"publisher","first-page":"116644","DOI":"10.1016\/j.lfs.2019.116644","volume":"232","author":"Y Dong","year":"2019","unstructured":"Dong, Y., Lu, H., Li, Q., Qi, X., Li, Y., Zhang, Z., Chen, J., & Ren, J. (2019). (5R)-5-hydroxytriptolide ameliorates liver lipid accumulation by suppressing lipid synthesis and promoting lipid oxidation in mice. Life Sciences, 232, 116644.","journal-title":"Life Sciences"},{"key":"5584_CR10","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.3892\/etm.2016.3739","volume":"12","author":"JZ Zeng","year":"2016","unstructured":"Zeng, J. Z., Ma, L. F., Meng, H., Yu, H. M., Zhang, Y. K., & Guo, A. (2016). (5R)-5-hydroxytriptolide (LLDT-8) prevents collagen-induced arthritis through OPG\/RANK\/RANKL signaling in a rat model of rheumatoid arthritis. Exp Ther Med, 12, 3101\u20133106.","journal-title":"Exp Ther Med"},{"key":"5584_CR11","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1124\/jpet.106.101113","volume":"318","author":"R Zhou","year":"2006","unstructured":"Zhou, R., Tang, W., Ren, Y. X., He, P. L., Zhang, F., Shi, L. P., Fu, Y. F., Li, Y. C., Ono, S., Fujiwara, H., Yang, Y. F., & Zuo, J. P. (2006). (5R)-5-hydroxytriptolide attenuated collagen-induced arthritis in DBA\/1 mice via suppressing interferon-gamma production and its related signaling. Journal of Pharmacology and Experimental Therapeutics, 318, 35\u201344.","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"5584_CR12","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1042\/BST20180445","volume":"47","author":"PY Ng","year":"2019","unstructured":"Ng, P. Y., Patricia Ribet, B., A. and, & Pavlos, N. J. (2019). Membrane trafficking in osteoclasts and implications for osteoporosis. Biochemical Society Transactions, 47, 639\u2013650.","journal-title":"Biochemical Society Transactions"},{"key":"5584_CR13","doi-asserted-by":"publisher","first-page":"166902","DOI":"10.1016\/j.bbadis.2023.166902","volume":"1870","author":"H Tan","year":"2023","unstructured":"Tan, H., Ma, L., Qin, T., Liu, K., Liu, Y., Wen, C., You, K., Pang, C., Luo, H., Wei, L., Shu, Y., Yang, X., Shen, X., & Zhou, C. (2023). Myo6 mediates osteoclast function and is essential for joint damage in collagen-induced arthritis. Biochim Biophys Acta Mol Basis Dis, 1870, 166902.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"5584_CR14","doi-asserted-by":"crossref","unstructured":"Jeong, C., Lee, C. H., Lee, Y., Seo, J., Wang, W., Park, K. H., Oh, E., Cho, Y., Park, C., Son, Y. J., Park, Y., Kang, J. H., H. and, & Lee, K. W. (2023). Ulmus Macrocarpa hance trunk bark extracts inhibit RANKL-induced osteoclast differentiation and prevent ovariectomy-induced osteoporosis in mice. Journal of Ethnopharmacology, 319,117285.","DOI":"10.1016\/j.jep.2023.117285"},{"key":"5584_CR15","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12906-015-0566-y","volume":"15","author":"Y Shen","year":"2015","unstructured":"Shen, Y., Jiang, T., Wang, R., He, S., Guo, M., Zuo, J., & He, D. (2015). (5R)-5-Hydroxytriptolide (LLDT-8) inhibits osteoclastogenesis via RANKL\/RANK\/OPG signaling pathway. Bmc Complementary and Alternative Medicine, 15, 77.","journal-title":"Bmc Complementary and Alternative Medicine"},{"key":"5584_CR16","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1136\/ijgc-2018-000038","volume":"29","author":"M Osakabe","year":"2019","unstructured":"Osakabe, M., Fukagawa, D., Sato, C., Sugimoto, R., Uesugi, N., Ishida, K., Itamochi, H., Sugiyama, T., & Sugai, T. (2019). Immunohistochemical analysis of the epithelial to mesenchymal transition in uterine carcinosarcoma. International Journal of Gynecological Cancer, 29, 277\u2013281.","journal-title":"International Journal of Gynecological Cancer"},{"key":"5584_CR17","doi-asserted-by":"crossref","unstructured":"Chen, Z., Cheng, Z., Tang, Z., Li, M., Tang, X., Zhang, H., & Sun, L. (2023). Interleukin-13 reduces bone erosion in rheumatoid arthritis by up-regulating osteoprotegerin expression in fibroblast-like synoviocytes: An in vitro and in vivo study. Clinical and Experimental Rheumatology, 41, 2151\u20132161.","DOI":"10.55563\/clinexprheumatol\/b96n1e"},{"key":"5584_CR18","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s42358-023-00294-3","volume":"63","author":"TO Quaresma","year":"2023","unstructured":"Quaresma, T. O., de Almeida, S. C. L., da Silva, T. A., Louzada-Junior, P., & de Oliveira, R. D. R. (2023). Comparative study of the synovial levels of RANKL and OPG in rheumatoid arthritis, spondyloarthritis and osteoarthritis. Adv Rheumatol, 63, 13.","journal-title":"Adv Rheumatol"},{"key":"5584_CR19","doi-asserted-by":"publisher","first-page":"605616","DOI":"10.3389\/fimmu.2021.605616","volume":"12","author":"X Zhou","year":"2021","unstructured":"Zhou, X., Xie, D., Huang, J., Lu, A., Wang, R., Jin, Y., Zhang, R., Chang, C., Xu, L., Xu, L., Fan, J., Liang, C., & He, D. (2021). Therapeutic effects of (5R)-5-Hydroxytriptolide on Fibroblast-Like synoviocytes in rheumatoid arthritis via LncRNA WAKMAR2\/miR-4478\/E2F1\/p53 axis. Frontiers in Immunology, 12, 605616.","journal-title":"Frontiers in Immunology"},{"key":"5584_CR20","first-page":"100724","volume":"34","author":"W Cao","year":"2023","unstructured":"Cao, W., Liu, X., Han, Y., Song, X., Lu, L., Li, X., Lin, L., Sun, L., Liu, A., Zhao, H., Han, N., Wei, H., Cheng, J., Zhu, B., Wang, M., Li, Y., Ma, P., Gao, L., Wang, X., Yu, J., Zhu, T., Routy, J. P., Zuo, M., & Li, T. (2023). (5R)-5-hydroxytriptolide for HIV immunological non-responders receiving ART: A randomized, double-blinded, placebo-controlled phase II study. Lancet Reg Health West Pac, 34, 100724.","journal-title":"Lancet Reg Health West Pac"},{"key":"5584_CR21","doi-asserted-by":"publisher","first-page":"816477","DOI":"10.3389\/fphar.2021.816477","volume":"12","author":"K Qian","year":"2021","unstructured":"Qian, K., Zheng, X. X., Wang, C., Huang, W. G., Liu, X. B., Xu, S. D., Liu, D. K., Liu, M. Y., & Lin, C. S. (2021). beta-Sitosterol inhibits rheumatoid synovial angiogenesis through suppressing VEGF signaling pathway. Frontiers in Pharmacology, 12, 816477.","journal-title":"Frontiers in Pharmacology"},{"key":"5584_CR22","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1038\/aps.2012.108","volume":"33","author":"W Tang","year":"2012","unstructured":"Tang, W., & Zuo, J. (2012). Immunosuppressant discovery from tripterygium wilfordii Hook f: The novel triptolide analog (5R)-5-hydroxytriptolide (LLDT-8). Acta Pharmacologica Sinica, 33, 1112\u20131118.","journal-title":"Acta Pharmacologica Sinica"},{"key":"5584_CR23","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1111\/j.1365-2125.2012.04221.x","volume":"74","author":"R Han","year":"2012","unstructured":"Han, R., Rostami-Yazdi, M., Gerdes, S., & Mrowietz, U. (2012). Triptolide in the treatment of psoriasis and other immune\u2010mediated inflammatory diseases. British Journal of Clinical Pharmacology, 74, 424\u2013436.","journal-title":"British Journal of Clinical Pharmacology"},{"key":"5584_CR24","first-page":"943","volume":"152","author":"EM Gravallese","year":"1998","unstructured":"Gravallese, E. M., Harada, Y., Wang, J. T., Gorn, A. H., Thornhill, T. S., & Goldring, S. (1998). Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis. The American Journal of Pathology, 152, 943.","journal-title":"The American Journal of Pathology"},{"key":"5584_CR25","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nrrheum.2012.153","volume":"8","author":"G Schett","year":"2012","unstructured":"Schett, G., & Gravallese, E. (2012). Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment. Nature Reviews Rheumatology, 8, 656\u2013664.","journal-title":"Nature Reviews Rheumatology"},{"key":"5584_CR26","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.abb.2008.03.018","volume":"473","author":"BF Boyce","year":"2008","unstructured":"Boyce, B. F., & Xing, L. (2008). Functions of RANKL\/RANK\/OPG in bone modeling and remodeling. Archives of Biochemistry and Biophysics, 473, 139\u2013146.","journal-title":"Archives of Biochemistry and Biophysics"},{"key":"5584_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12906-015-0566-y","volume":"15","author":"Y Shen","year":"2015","unstructured":"Shen, Y., Jiang, T., Wang, R., He, S., Guo, M., Zuo, J., & He, D. (2015). (5R)-5-Hydroxytriptolide (LLDT-8) inhibits osteoclastogenesis via RANKL\/RANK\/OPG signaling pathway. BMC Complementary and Alternative Medicine, 15, 1\u201310.","journal-title":"BMC Complementary and Alternative Medicine"}],"container-title":["Applied Biochemistry and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-026-05584-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12010-026-05584-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-026-05584-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T09:12:43Z","timestamp":1774689163000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12010-026-05584-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,20]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["5584"],"URL":"https:\/\/doi.org\/10.1007\/s12010-026-05584-2","relation":{},"ISSN":["0273-2289","1559-0291"],"issn-type":[{"value":"0273-2289","type":"print"},{"value":"1559-0291","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,20]]},"assertion":[{"value":"7 January 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by Guanghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine. This study was performed in strict accordance with the NIH guidelines for the care and use of laboratory animals (NIH Publication No. 85\u2009\u2212\u200923 Rev. 1985).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"The authors declare no conflicts of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}